Cargando…

Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody

Detalles Bibliográficos
Autores principales: Teng, Fei, Peng, Jin-Min, Wang, Qian, Tian, Xin-Lun, Huo, Zhen, Weng, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078295/
https://www.ncbi.nlm.nih.gov/pubmed/33252377
http://dx.doi.org/10.1097/CM9.0000000000001235
_version_ 1783685029944098816
author Teng, Fei
Peng, Jin-Min
Wang, Qian
Tian, Xin-Lun
Huo, Zhen
Weng, Li
author_facet Teng, Fei
Peng, Jin-Min
Wang, Qian
Tian, Xin-Lun
Huo, Zhen
Weng, Li
author_sort Teng, Fei
collection PubMed
description
format Online
Article
Text
id pubmed-8078295
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-80782952021-04-27 Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody Teng, Fei Peng, Jin-Min Wang, Qian Tian, Xin-Lun Huo, Zhen Weng, Li Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2021-04-20 2020-11-25 /pmc/articles/PMC8078295/ /pubmed/33252377 http://dx.doi.org/10.1097/CM9.0000000000001235 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Teng, Fei
Peng, Jin-Min
Wang, Qian
Tian, Xin-Lun
Huo, Zhen
Weng, Li
Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
title Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
title_full Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
title_fullStr Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
title_full_unstemmed Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
title_short Successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
title_sort successful treatment with tocilizumab in a patient with rapidly progressive interstitial lung disease with positive anti-melanoma differentiation-associated gene-5 antibody
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078295/
https://www.ncbi.nlm.nih.gov/pubmed/33252377
http://dx.doi.org/10.1097/CM9.0000000000001235
work_keys_str_mv AT tengfei successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody
AT pengjinmin successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody
AT wangqian successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody
AT tianxinlun successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody
AT huozhen successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody
AT wengli successfultreatmentwithtocilizumabinapatientwithrapidlyprogressiveinterstitiallungdiseasewithpositiveantimelanomadifferentiationassociatedgene5antibody